Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN1538950A details a mild transfer hydrogenation method for amine synthesis using Ru/Rh catalysts, offering cost reduction in API manufacturing and high optical purity.
Patent CN104673733B reveals a novel HHDH enzyme route for high-purity statin intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN106316825A reveals a scalable chemical route for trans-4-hydroxycyclohexanecarboxylic acid. This method offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing.
Patent CN102558098A details a one-pot synthesis for EGFR inhibitor intermediates, offering significant cost reduction in API manufacturing and improved supply chain reliability.
Novel one-pot synthesis of Tetraestrone improves yield and reduces cost for veterinary pharmaceutical supply chains globally.
Novel patent CN117430650B enables high-purity ivermectin recovery from waste. Reduces hazardous waste and offers cost-effective pharmaceutical intermediate manufacturing solutions.
Patent CN85103245A details novel rhodium-diphosphine complexes enabling high-yield asymmetric hydrogenation for pharmaceutical intermediates with reduced catalyst loading.
Patent CN104693194B details organic base catalysis for oxindole derivatives offering cost reduction and high purity for pharmaceutical supply chains.
Patent CN107698590A details asymmetric cyclization for high-purity nucleosides. Offers cost reduction in API manufacturing and scalable supply chain solutions.
Novel ionic liquid method for 16α-hydroxyprednisolone. Reduces waste and cost. Reliable pharmaceutical intermediates supplier for global supply chains.
Novel Raney Ni catalyzed method for N-[2-(phenylmethyl)phenyl]-2-chloroacetamide. Reduces cost and pollution significantly. Reliable pharmaceutical intermediates supplier.
Novel patent CN101591346B details high-yield synthesis route offering substantial cost reduction and supply chain reliability for global pharmaceutical intermediate manufacturing.
Patent CN101434609B details a tungstate-catalyzed oxidation of 6-APA. This green process offers high yield and safety for reliable pharmaceutical intermediate supply chains.
Patent CN104447539B enables efficient aromatic amide production. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Novel mild temperature process for high-purity Valnemulin. Eliminates chromatography, reducing costs for antibiotic manufacturers.
Patent CN102070483A reveals acetone-based lidocaine synthesis offering higher purity and environmental benefits for reliable pharmaceutical intermediate supply chains.
Patent CN110305142A details stereoselective synthesis improving purity. Offers supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN105153169A reveals a safer synthesis route for Epinastine Hydrochloride, eliminating toxic reagents and enhancing supply chain reliability for pharmaceutical manufacturing.
Novel enzymatic route for 4-AA intermediate reduces costs and improves purity for penem antibiotic manufacturing supply chains globally.
Patent CN104651292A reveals high-purity S-CHBE synthesis via recombinant E. coli. Achieves 100% conversion and 99.4% ee for scalable pharmaceutical intermediates.